Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens
Presbyopia
About this trial
This is an interventional treatment trial for Presbyopia
Eligibility Criteria
Key Inclusion Criteria: Able to understand and sign an consent form (ICF) that has been approved by an Institutional Review Board (IRB); Willing to stop wearing habitual contact lenses for the duration of study participation; Currently wearing multifocal soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months; Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: Any eye infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator; Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator; History of refractive surgery, or plan to have refractive surgery during the study; Current or history of dry eye in either eye that would preclude contact lens wear, in the opinion of the investigator; Monovision contact lens wear; Other protocol-defined exclusion criteria may apply.
Sites / Locations
- Johns Creek Research Clinic
Arms of the Study
Arm 1
Arm 2
Other
Other
LID#224381, then AOHG MF
AOHG MF, then LID#224381
Lehfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second in pre-determined order. Each study lens type will be worn bilaterally (in both eyes) for approximately 2 days. CLEAR CARE will be used for nightly cleaning and disinfection.
Lotrafilcon B multifocal contact lenses worn first, with lehfilcon A multifocal contact lenses worn second in pre-determined order. Each study lens type will be worn bilaterally (in both eyes) for approximately 2 days. CLEAR CARE will be used for nightly cleaning and disinfection.